Tag: life sciences
-
Brain-Computer Link in Development for Spinal Injury
A consortium of engineering labs is designing a system translating commands in the brain to prosthetic devices that help people walk with spinal cord injury.
-
Cochlear Implant Robotics Start-Up Gains NIH Funds
A university spin-off enterprise developing robotics to make cochlear implants for hearing loss safer and more effective is receiving a Small Business Innovation Research, or SBIR, grant to advance its technology.
-
Microchips Designed for Tracking Bodily Functions
Engineering researchers designed a tiny chip device that identifies precise locations inside the body, a key feature for ingestible medical devices.
-
Synthetic DNA Start-Up Raises $13M in Early Funds
A company producing synthesized DNA for medical and other biotechnology applications is raising €11 million ($US 13 million) in its first venture funding round.
-
Trial Shows Antibody Effective Against Asthma
Results from a large-scale clinical trial show a synthetic antibody, when added to standard treatments, reduces asthma attacks and improves lung functioning.
-
Risks of E-Cigarette Use, Ingredients Highlighted
Several sessions at a scientific meeting on respiratory diseases report on effects of electronic cigarettes on people’s health, including those who also smoke conventional cigarettes.
-
University, Drug Maker Partner on Suicide Genetics
Pharmaceutical company Janssen Research and Development and University of Utah Health in Salt Lake City are studying genetic factors linked to higher suicide risks.
-
NIH Funds Heart Tissue Regeneration Tests in Pigs
An experimental drug to help grow new heart tissue after a heart attack is advancing to tests in pigs, with help from National Institutes of Health.
-
Wearable-Implant Diagnostics Device in Development
A university engineering lab is developing a device combining a sensor chip implanted under the skin and wrist band to diagnose serious diseases and transmit the data.
-
Start-Up Lands $10M for Gene-Editing HIV Treatments
A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round.